Stock Ticker

  • Loading stock data...

Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) – Nuvigil Patent Infringement Lawsuit Resolved

Boston, MA 06/20/2014 (wallstreetpr) – Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) continues to file a series of patent infringement lawsuits against various company as it seeks to protect its products from generic competition. It goes without saying that some of these cases result in unnecessary expenses, prompting companies to opt for early settlement as it […]

Mylan Inc (NASDAQ:MYL): Will It Create An Entry Into Pain Management?

Boston, MA 06/05/2014 (wallstreetpr) – Mylan Inc (NASDAQ:MYL) settles the patent litigation with Pfizer relating to the generic version of Celebrex. The Company filed the Abbreviated New Drug Application (ANDA) with the FDA for Celebrex capsules. The product primarily uses for the treatment of arthritis and pain management in adults. Legal Settlement Celebrex’s patent will […]

Mylan Inc. (NASDAQ:MYL) Manages license Agreement With Pfizer Inc. (NYSE:PFE) For Generic Version Of Celebrex

Boston, MA 06/04/2014 (wallstreetpr) – Mylan Inc. (NASDAQ:MYL) made an official announcement about its license agreement to sell the generic version of the painkiller capsules Celecoxib, also referred popularly as Celebrex, with Pfizer Inc. (NYSE:PFE). Abbreviated New Drug Application (ANDA) In answer to the aforementioned application made by Mylan Inc. (NASDAQ:MYL) to the US FDA, […]

Competition Stricken Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) May Look For India Deal Despite Denial

Boston, MA 05/23/2014 (wallstreetpr) – The Israel-based drug company Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has taken several doses of its own medicine in recent times. The company that thrives in developing and marketing generic drugs has in recent times until last week tried to stop competitors from developing a copycat of its bestselling Copaxone […]